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cachexia, and paralysis due to viral-induced T-cell lymphomas that ultimately result in death. The primary
mode of MD control has been via the use of vaccines, which has signiﬁcantly reduced losses due to MD
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11E. Hildebrandt et al. / Virology Reports 5 (2015) 10–18since the 1970s (Purchase and Okazaki, 1971). Despite thewidespread use of vaccinal control of MD
strains of MDV able to overcome vaccines have emerged, leading to the need for periodic introductio
and more effective MD vaccines approximately every 10 years (Witter, 1997). Currently the most p
vaccine commercially available, CVI988/Rispens, has been in use in the United States since the 1990s
regarding the potential for MD outbreaks in Rispens-vaccinated ﬂocks has highlighted the impor
vaccine development (Gimeno, 2008). One common method for vaccine production has been t
live attenuated viruses generated via repeated in vitro serial passage. Several MD vaccines, such a
16 and Rispens, were generated by in vitro serial passage and provide testament to the utility of th
in vaccine development (Churchill et al., 1969; Rispens et al., 1972).
To better understand this process and identify candidate genes involved in attenuation, previou
rially passed and sequenced the complete genome of four attenuatedMDV replicates (threeMd5BA
viruses and one Md5 strain) to identify candidate mutations and genes involved in attenuation (Hi
et al., 2014). Several candidate mutations present within genes in the unique long (UL) or unique s
regions of the viral genomewere characterized via recombinant viruses. Among the ﬁve pointmutat
ed, one recombinant virus revealed a single nucleotide mutation in UL5 (helicase–primase subun
reduce disease incidence by 90% or more. Due to the additional complexity involved in mutati
present within the two long and short repeat regions (TRL/IRL and TRS/IRS) in MDV, these c
mutations were not initially tested. Therefore, the purpose of this study was the characterizatio
candidate gene identiﬁed within the repeat regions of the MDV genome.
ICP4, encoded by RS1, is an immediate early transcriptional regulator in herpesviruses located w
TRS/IRS region ofMDV and a gene commonlymutated in all of the attenuated replicates. All four pas
es hadmutations within ICP4, with three viruses containing high frequency (80–100%) nonsynonym
tations within amino acids 60–63 in ICP4. Three other high frequency (40% or higher) nonsyn
mutations in ICP4 were also observed, including one at amino acid position 1630 (85% frequency
these numerous high frequency, parallel mutations within the attenuated replicates, ICP4 was con
candidate gene for attenuation. Using Red-mediated recombineering, we generated two recombina
to examine how these mutations in ICP4 impacted virulence of MDV.
2. Results
2.1. In vivo trials
Disease incidences resulting from challengewith eitherMut ICP4-1 (single ICP4 Q63H SNV) orM
(double Q63H and S1630P SNVs) were 100% and 95%, respectively. Compared to the parental v
showed 84% MD incidence there was no signiﬁcant difference between MD incidence of the
Md5B40BAC-c1 and either recombinant ICP4 viruses (Fischer's exact test p = 0.5320), therefo
Table 1
Mutational primers for generation of recombinant ICP4 viruses.
Primer name Sequence
ΔICP4-f TTGTCTAAATTGTTATGAGGTTTGGGGACAATATTTATTGACTAGTCTtagggataacagggtaatcgattt
ΔICP4-r CCACCATCTATTTGCGCCCCTCCTAAACCCTAAAAATGGACAACCCGCCTAGACTAGTCAATAAATATTGTCCCCAAACC
TCATAACAATTTAGACAAgccagtgttacaaccaattaacc
Mut ICP4 Q63H-f GCTAGCCGGACAATCGGGTACATACCGCCCCCACTCCAGTTACCATGGACAtCGCTCGCTTTCCAGCGGCCC
tagggataacagggtaatcgattt
Mut ICP4 Q63H-r GGCTATGGGCAGCGGGGACGGGGCCGCTGGAAAGCGAGCGaTGTCCATGGTAACTGGAGTGGGGGCGGT
ATGgccagtgttacaaccaattaacc
Mut ICP4 S1630P-f ACCCGATCAGCTGTTTCGAGGTCCTGGGCGTCCCCGACGCcCCACTTCATCATCCCAGTCTtagggataacagggtaatcgattt
Mut ICP4 S1630P-r ATGGGAGATTTATCAGACGCAGACTGGGATGATGAAGTGGgGCGTCGGGGACGCCCAGGACgccagtgttacaaccaattaacc
Nucleotides in uppercase indicate the region of primer homologous to MDV for integration into the MDV genome while nucleotides in
lowercase are regions complementary to the kanamycin cassette. The single lowercase nucleotide in bold and underlined indicates the
point mutation altered for generation of recombinant viruses.
mutations did not reduce virulence of the viruses in infected birds (Table 2). While most challenged birds de-
veloped MD, the disease incidences in contact birds varied signiﬁcantly between the two recombinant ICP4
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Table 2
MD incidence of recombinant ICP4 mutant viruses.
Challenge virus MD incidence in challenged birds MD incidence in contact birds
# MD+ birds/Total birds Percent MD # MD+ birds/Total birds Percent MD
Mut ICP4-1 10/10a 100 5/5 100
Mut ICP4-2 18/19a 95 0/5 0
Md5B40BAC-c1 16/19a 84 4/5 80
a Due to chick mortality during the ﬁrst two weeks of age in isolators challenged with Mut ICP4-1, fewer total birds were available
compared to Mut ICP4-2 and Md5B40BAC.
12 E. Hildebrandt et al. / Virology Reports 5 (2015) 10–18viruses. Contact birds housed with the Mut ICP4-1 virus all developed MD, yet no contact birds m
birds challenged with the Mut ICP4-2 recombinant virus developed MD (Table 2).
While both recombinant viruses resulted in over 90% disease incidence, there was delayed mo
birds challenged with the double Mut ICP4-2 recombinant virus compared to Mut ICP4-1 and Md
c1. Birds challenged with the single Mut ICP4-1 recombinant virus experienced survival compara
original Md5B40BAC-c1 (Fig. 1). On the other hand, the double Mut ICP4-2 virus exhibited lower
fromweek 4 onwards (Fig. 1), with approximately 20% of birds surviving the full length of the 12we
iment compared to birds challenged with either Mut ICP4-1 or Md5B40BAC-c1 which were all euth
week 10.
Replication ofMDVwithin the spleen of birds sacriﬁced at 7, 14 and 21 dpi as determined by qPC
a range among the three viruses (Fig. 2). Compared to Mut ICP4-1 and the wild-type Md5B40BAC
double mutant Mut ICP4-2 recombinant virus showed lower levels of in vivo replication at 7 an
with signiﬁcant differences in replication at day 14 (ANOVA p-value = 0.0136), though this differ
not observed at 21 dpi. Further pairwise comparisons of in vivo replication at day 14 showed signi
ferences in replication between Mut ICP4-1 and Md5B40BAC-c1, with differences between Mut IC
Md5B40BAC-c1 falling short of the threshold for signiﬁcance (T-test p = 0.0101 and p =
respectively).Fig. 1. Survival curves of birds challenged with recombinant MDV. Mortality of birds during the 12 week experiment until termination
was compared for the two ICP4 mutant viruses relative to the parental Md5B40BAC virus.
2.2. Homology of alphaherpesviruses' ICP4 protein sequence
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Fig. 2. Viral replication rates of birds challenged with recombinant MDV. In vivo replication of recombinant ICP4 MDV versus parental
Md5B40BAC virus.
13E. Hildebrandt et al. / Virology Reports 5 (2015) 10–18Comparing the prototypical alphaherpesvirus (HSV-1) to the 20 alphaherpesviruses' sequ
pairwise alignment of HSV-1 to each respective species sequence showed a high degree of variatio
ICP4 sequences between species. Amino acid sequence identity for ICP4 of the 20 species surveye
to HSV-1 ranged from approximately 15–71%, with an average shared sequence identity of 36
Table 1). Alignment of HSV-1 to Mardivirus sequences show an average sequence identity of 17
the three Mardivirus species, versus an average shared sequence identity of 39% for HSV-1 alignm
the non-Mardivirus species. Alignment of HSV-1 ICP4 and the virulent MDV ICP4 sequences rev
lowest degree of shared sequence identity of approximately 15%.
Alignment of all 20 ICP4 sequences showed a high degree of variation among the alphaherp
surveyed, not only in coding sequence but also in total length. The average length of ICP4
alphaherpesviruses surveyed was approximately 1500 amino acids. However, the average length
theMardivirus species infecting chicken (Gallid herpesvirus 2, Gallid herpesvirus 3 andMeleagrid he
1) revealed signiﬁcantly larger (2173 amino acids) ICP4 proteins, with Gallid herpesvirus 2 having th
sequence of any herpesvirus species surveyed at 2323 amino acids (Supp. Table 1). Themajority of th
ly 700 additional amino acids are found at the N terminus of ICP4 inMardiviruses. Clustal alignment
herpesvirus species show that for the ﬁrst 500 amino acids of MDV ICP4, the only species with ho
amino acids to this region are Gallid herpesvirus 3 and Meleagrid herpesvirus 1, both of which al
to theMaridvirus genus (Supp. Fig. 1). Furthermore, the cluster of high frequencymutationswithin I
tiﬁed in the attenuated MDV replicates around amino acids 60–63 occurs within this additional reg
unique relative to other alphaherpesviruses. Even among Mardiviruses that possess a longer ICP4, t
around amino acids 55–79 is exclusively found only in the virulent Gallid herpesvirus 2 species, p
functional predictions for this mutated region based on homology to other species (Supp. Fig. 1).
The alignment of ICP4 sequences showed that the region surrounding the second mutation at a
1630 is a position present in the majority of herpesvirus species, although there is considerable va
the amino acids present at this position (Supp. Fig. 2). The MDV wild type serine is an amino aci
other herpesvirus species, such as Gallid herpesvirus 1 and both HSV-1 and HSV-2. The mutation o
to proline residue at position 1630 is predicted to be a tolerated change by programs such as SIFT (Kumar
et al., 2009), as well as an evolutionarily acceptable amino acid considering that proline is commonly seen
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14 E. Hildebrandt et al. / Virology Reports 5 (2015) 10–18in several herpesvirus species, such as Equid herpesvirus 1, Suid herpesvirus 1, Psittacid herpesvi
the closely related Meleagrid herpesvirus 1 (Supp. Fig. 2). Based on the alignment to HSV-1,
S1630P ICP4mutation corresponds to roughly the same serine residue at position 683 in HSV-1. Thi
is expected to be a globular region within the third deﬁned region of ICP4 in HSV-1. This position is
acterized as occurring within a functional domain implicated for nuclear localization (Wyr
Rychlewski, 2007), yet the corresponding amino acid regions within MDV ICP4 do not appear to
known nuclear localization signal surrounding the mutated region in MDV ICP4 based on various p
programs (NucPred, NLS Mapper and NLStradamus; data not shown).
Our phylogenetic tree constructed based on the complete sequence of ICP4 from the 20 he
species had an overall topology and grouping comparable to trees previously constructed using a co
of several genes (McGeoch and Cook, 1994; McGeoch et al., 2000). However, despite the overall sim
most genera between the two trees, there was a change in the relationship of the virulent Iltovirus,
ILTV, and Gallid Mardiviruses for this tree generated based only on ICP4 compared to previously co
trees. The resulting ICP4 tree has the most closely related sister taxa classiﬁed as the virule
herpesvirus-2 and ILTV, which are shown to split from the avirulent Gallid herpesvirus-3 and Mele
pesvirus 1 lineage (Fig. 3). This yields classiﬁcation of these three Mardiviruses and single Iltoviru
along lines of virulence, unlike previous studies that classify these species relationships based o
lines. This relationship is dependent upon highly variable regions within ICP4, as trimming ICP4 s
to only use regions known to be highly conserved among alphaherpesviruses, such as region
(Wyrwicz and Rychlewski, 2007; McGeoch et al., 1986), results in a phylogenetic tree with the
grouping of the Mardivirus and Iltovirus genera as separate branches (data not shown).
3. Discussion, ICP4 was
4). These
es of 96%,During a previous in vitro serial passage of MDV to ﬁnd candidate genes involved in attenuation
found to bemutated repeatedly in all attenuated MDV replicates sequenced (Hildebrandt et al., 201
attenuated viruses contained nonsynonymous mutations at amino acids 60, 62 and 63 at frequenci
Gallid herpesvirus 1
Gallid herpesvirus 2
Gallid herpesvirus 3
Meleagrid herpesvirus 1
Anatid herpesvirus 1
Bovine herpesvirus 1
Suid herpesvirus 1
Equid herpesvirus 1
Canid herpesvirus 1
Felid herpesvirus 1
Human herpesvirus 3
Cercopithecine herpesvirus 9
Psittacid herpesvirus 1
Macropodid herpesvirus 1
Saimiriine herpesvirus 1
Human herpesvirus 2
Chimpanzee alpha-1 herpesvirus
Macacine herpesvirus 1
Cercopithecine herpesvirus 2
Papiine herpesvirus 2
UL36 tegument protein Gallid herpesvirus 2
Fig. 3.Maximum likelihood phylogenetic tree based on the complete amino acid sequence of ICP4 from20herpesvirus species. Artiﬁcially
rooted with the outgroup of UL36 amino acid sequence from Gallid herpesvirus 2.
83% and 100%, respectively, in three of the four attenuated populations. Besides these clustered mutations,
three more nonsynonymous mutations exceeding frequencies of 40% or more were also seen at other posi-
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15E. Hildebrandt et al. / Virology Reports 5 (2015) 10–18tions within ICP4 in the attenuated replicates. In addition to these serially passed Md5 replicates, m
within ICP4 in attenuated MDV have been identiﬁed by other groups as well. During serial passag
quencing of an attenuated 648A strain of MDV, three high frequency mutations within I
nonsynonymous and one silentmutation,were foundwithin the attenuated strain (Spatz, 2010). Ev
complete genome sequence analysis of the current “gold-standard”MD vaccine known as Rispens, m
were found within ICP4 (Spatz et al., 2007). Studies including alphaherpesviruses besides MDV als
similar trend of mutations within ICP4 in attenuated viruses. Complete genome sequencing of an a
and highly passed vaccine strain of the pseudorabies virus, Suid herpesvirus 1, identiﬁed 11mutatio
ICP4 that were unique to a vaccine strain compared to two sequenced virulent strains (Szpara et a
Furthermore, in the Oka vaccine strain of the varicella-zoster virus (VZV), also known as human he
3 (HHV-3), a disproportionate number of mutations (15 with 8 of which were nonsynonymous) w
within ICP4 in the vaccine strain relative to the virulent parental virus (Gomi et al., 2002).
Despite evidence from a variety of attenuated alphaherpesviruses suggesting that mutations w
may be a causative factor driving attenuation of the virus, the two recombinant viruses tested c
high frequency candidate SNVs within ICP4 did not cause any reduction in virulence of MDV, alth
Mut ICP4-2 recombinant virus did fail to transmit horizontally to contact birds. Recombinant MD
that are virulent and inducedMD in challenged birds but failed to transmit horizontally to causeMD
birds have been previously reported for mutations in UL44 (gC) and UL13 (protein kinase) (Jarosin
2007; Jarosinski and Osterrieder, 2010), as well as with a recombinant virus with a point mutatio
LORF2 (Hildebrandt et al., 2014). One possible explanation for the failure of Mut ICP4-2 to infec
birds is due to lower levels of in vivo replication at days 7 and 14, during the times traditionally cla
early cytolytic and latent phases of infection (Baigent and Davison, 2004). The lowest virus load a
three time points was seen during the transition between the early cytolytic phase to latency (
Mut ICP4-2. This could affect transmission of the recombinant virus because as chickensmature the
an age-related resistance towardsMD. Therefore, young chicks aremost susceptible toMDV infectio
to a decrease or delay in shedding of virulentMDVbyMut ICP4-2, the potential for transmission and
to older contact birds would decrease (Jarosinski et al., 2007). Alternatively, thesemutationswithin
impair replication within the feather follicles, leading to an inability to spread through shed feathe
Despite the indication that mutations within ICP4 appear to be correlated with attenuation in a m
of alphaherpesviruses, recombinant viruses containing point mutations within ICP4 show that m
within ICP4 alone are not sufﬁcient for attenuation in MDV. This conclusion is supported by exp
using the Oka vaccine strain of VZV in which transactivation of downstream promoters regulate
was compared between mutated versions of ICP4 from the vaccine strain versus the parental vir
et al. (2006) established that regulation and transcription of downstream promoters between the
andwild-type ICP4were comparable, leading to their conclusion thatmutationswithin ICP4 alone ar
ﬁcient to cause attenuation.
Mutations within the VZV Oka vaccine strain did not affect transactivation of viral promoters
known that ICP4 contains different regions with speciﬁc functions in addition to transactivation
DNA binding, nuclear localization, and regulation of late genes (Wyrwicz and Rychlewski, 2007). T
we sought to computationally determine what function observed mutations within MDV ICP4 ma
particularly those within amino acids 60–63, which contained mutations in three completely at
MDV replicates via sequence comparisons to other alphaherpesviruses. Alignment of the comple
acid sequence of ICP4 revealed signiﬁcant variation among alphaherpesviruses, which has previo
described. It is known that certain regions of ICP4, such as regions 2 and 4, are highly conserved am
pesviruses, while other regions are not particularly well conserved among species, such as regions
(Wyrwicz and Rychlewski, 2007; McGeoch et al., 1986). Speciﬁcally, comparisons among genera s
Mardiviruses have a signiﬁcantly longer ICP4 of approximately 2173 amino acids in length compa
average length of 1500 amino acids for non-Mardiviruses. Furthermore, in our attenuated MDV
containing several high frequency mutations around amino acids 60–63, these mutations occur
region found uniquely in MDV yet absent in other closely related Mardiviruses. Considering tha
not only virulent, but is also an oncogenic virus, unlike all other alphaherpesviruses which do
tumors, it is difﬁcult to predict what role these unique regions in MDV ICP4 provide during the lif
this oncogenic herpesvirus, particularly in light that closely related apathogenic Mardiviruses lack this
commonly mutated region of ICP4.
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16 E. Hildebrandt et al. / Virology Reports 5 (2015) 10–18The second mutation at amino acid 1630 occurs at a position present within the 20 herpesviru
surveyed unlike the ﬁrst mutation at amino acid 63. The mutation of a serine residue to a proline a
1630 appears to be an evolutionary accepted change,with proline commonly found in several other
herpesviruses. Despite this apparently tolerated amino acid change, it is only with the addition of th
mutation at position 1630 in conjunctionwith themutation at amino acid 63 that changes in horizon
missionwere observed. The role for this secondmutation at position 1630 is difﬁcult to predict due t
degree of variation among herpesvirus species for amino acids within this designated region 3 of IC
has been shown to be less highly conserved than regions 2 and 4 (Wyrwicz and Rychlewski, 2007;
et al., 1986), leading to a poorer understanding of functional roles for diverse regions such as region 3
of MDV's ICP4 primary structure via software designed for modeling and prediction of protein struc
as forMDV ICP4 sequences predict that the regions ofMDV ICP4 containing the twomutations engin
foundwithin disordered, coiled regions of the protein but due to lack ofMDV ICP4 structural predict
data is available for hypothesizing the roles for the observed mutated regions.
Due to limitations of comparisons of ICP4 for speciﬁc amino acid positions among the herpesvi
veyed, further comparison of the entire ICP4 sequence via phylogenetic analysis of the 20 alphahe
species based on the complete ICP4 amino acid sequence showed a discrepancy between the rel
of Mardiviruses and Iltoviruses of chicken compared to traditional trees based on compilation of da
ing multiple genes. Previous studies have classiﬁed the three Mardiviruses (Melaeagrid herpesviru
herpesvirus 2 and Gallid herpesvirus 3) collectively in one group known as α3 viruses, while the
Gallid herpesvirus 1 (ILTV), was classiﬁed in a separate group designated α4 based on genera
would be expected (McGeoch et al., 2000). Instead, based on ICP4 sequences, these relationships are
in linewith genera classiﬁcation, but showcloser homology between the virulent viruses of Gallid he
2 and ILTV now grouped as sister taxa, despite belonging to different genera. Thus, it appears that t
be a greater commonality between evolutionary pressure affecting the sequence of ICP4within virul
es which affect chickens compared to other Mardi and Iltoviruses.
Collectively, this data suggests that mutations within ICP4 may play a supporting role in attenu
operatively with the addition of other mutations that directly reduce virulence. Due to a selective a
for viruses able to replicate faster during serial passage, mutations that impact in vitro replication
expected to occur within attenuated viruses despite the fact that those mutations themselves are n
tive for the loss of virulence resulting from serial passage. This would result in mutations that impa
replication to occur collectively with mutations that reduce virulence in vivo and are the causative
for attenuation and the loss of virulence. One such potential scenario for the attenuated MDV v
quenced involves a point mutation within the UL5 helicase–primase gene identiﬁed at 65% in an a
MDV viral population that likely could have occurred concurrently within the same viral genome c
the ICP4 mutation G62V present at 83% in the same population. This mutation in UL5 reduced vir
nearly 90% (Hildebrandt et al., 2014), therefore, it may be postulated that mutations within ICP4, w
viously have been proposed to provide a selective advantage during in vitro growth (Gomi et al., 20
result in attenuated viruses generated after repeated serial passage due to combination with a
mutations that alter virulence, such as the UL5 mutation.
Despite the large body of examples correlating mutations within ICP4 with attenuation
herpesviruses, it remains unknownwhat function thesemutationsmay impart to attenuated viruses
further characterization it would be difﬁcult to further postulate what role these additional 700 am
confer in MDV relative to other alphaherpesviruses, or understand the impact of the numerous m
within ICP4 seen not only within attenuated MDV, but among other alphaherpesviruses as well.
4. Conclusionsher Q63H
he loss of
ns withinDespite showingmultiple nonsynoymousmutations at high frequency in attenuatedMDVs, neit
nor S1630P mutations were sufﬁcient to reduce viral virulence and are not causative factors for t
virulence during in vitro serial passage. Therefore, recombinant MDVs with only deﬁned mutatio
ICP4 are not likely to be viable candidates as MD vaccines.
5. Materials and methods
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17E. Hildebrandt et al. / Virology Reports 5 (2015) 10–185.1. Recombinant viruses and tissue culture
ICP4 mutations were incorporated into Md5B40BAC, the pBeloBAC11 clone containing the en
(Md5 strain) genome, using Red-mediated recombineering (Jarosinski et al., 2007; Tischer et
Niikura et al., 2011). To generate recombinant viruses containing the desired single nucleotid
(SNV) within both copies of ICP4, one copy of ICP4 was ﬁrst deleted using the ΔICP4 primer set
based on the process of manipulating genes within repeat regions described by Engel et al. (2012). P
tations were then incorporated within the remaining copy of ICP4 via additional rounds of recom
using the primer sets Mut ICP4 Q63H and Mut ICP4 S1630P. The resulting mutants, designated as M
1 and Mut ICP4-2, both contained the mutation Q63H, while the latter also had the additional SNV
The Q63H mutation was ﬁxed 100% in one of the serially passed attenuated replicates during our
study (Hildebrandt et al., 2014), while the S1630Pmutation was the second highest frequency ICP4
within the same replicate present at 85%. All introducedmutationswere conﬁrmed via Sanger seque
fore transfecting the mutated BACs into duck embryo ﬁbroblasts (DEF) via the calcium phosphat
(Moriuchi et al., 1992) and viral stocks passed throughDEFs for four passages to amplify viral stocks.
ally, mutations in the generated viral stocks were conﬁrmed by Sanger sequencing. Viral stocks wer
trated on DEF cells to quantify the number of plaque forming units (PFU) in frozen viral stocks.
5.2. In vivo characterization of mutant viruses
Maternal antibody negative, ADOL 15I5 × 71 day old chicks were challenged intraabdomin
500 PFU of each recombinant MDV or the original Md5B40BAC-c1 as a positive control, and h
Horsfall–Bauer (HB) isolators for 12 weeks. Uninfected birds were housed as negative controls in a
isolator. All surviving birds, or those that weremoribund during the course of the experiment, were
ed and examined via necropsy to determine disease incidence. To determine horizontal transmiss
fected contact birds were housed in the same HB unit with challenged birds. Five infected bi
removed for sampling at 7, 14 and 21 days post infection (dpi) to collect spleen tissues to quant
replication of viruses via qPCR comparing the relative quantity of the MDV gB gene to chicken GA
using a Taqman Fast Universal PCR kit (Applied Biosciences; Foster City, CA) and primers des
Gimeno et al. (2008). All in vivo bird trials were approved by the USDA, Avian Disease and Oncolog
tory Animal Care and Use Committee (ACUC). Based on ACUC guidelines established and approv
ADOL ACUC (April 2005) and the Guide for the Care and Use of Laboratory Animals by the Institute
ratory Animal Research (2011), procedures for bird housing and care were followed throughout the
of the experiment.
5.3. Sequence comparison of ICP4 among alphaherpesviruses
The complete amino acid sequence of the immediate early transcriptional regulator gene ICP4
different species of alphaherpesviruses was obtained from the NCBI database. All 20 sequences wer
usingClustalW (Larkin et al., 2007) and amaximum likelihood phylogenic tree constructed inMega6
et al., 2013), while pairwise comparisons for each of the 20 ICP4 sequences relative to herpes simpl
(HSV-1) ICP4 (GenBank accession no. AGZ01922.1) were aligned via the UniProt protein resources
(The UniProt Consortium, 2014) to calculate the percentage of shared sequence identity am
sequences.
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.virep.2014
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